Position in LGND
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,702,569
+$110,913 QoQ
Shares Held
8,550
-34.1% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#136
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $221,188,371 across 29 Biotechnology names. LGND ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
368,978 | $105,147,660 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,845 | $32,950,970 | |
| 3 | INCY |
Incyte Corp
|
224,855 | $25,489,561 | |
| 4 | EXEL |
Exelixis, Inc.
|
437,138 | $23,784,676 | |
| 5 | INVA |
Innoviva, Inc.
|
274,391 | $6,231,419 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
38,672 | $2,880,290 | |
| 7 | ASND |
Ascendis Pharma A/S
|
10,735 | $2,863,239 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
This page
|
8,550 | $2,702,569 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,702,569 | 8,550 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,591,656 | 12,981 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,424,444 | 12,823 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,225,409 | 12,563 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,487,957 | 13,089 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,223,514 | 11,637 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,272,730 | 77,207 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,112,795 | 71,064 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,784,030 | 56,777 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,823,861 | 52,310 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,819,304 | 39,475 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,453,363 | 40,944 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,126,688 | 43,366 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $606,501 | 8,245 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $237,874 | 3,561 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $324,031 | 3,763 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $329,935 | 3,698 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $391,352 | 3,479 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $544,780 | 3,527 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $657,590 | 4,720 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $497,997 | 3,796 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $709,654 | 4,655 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $477,757 | 4,804 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $469,832 | 4,929 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $713,267 | 6,377 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $405,559 | 5,577 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||